课题基金 / 基金详情

S GORDONII AS A VECTOR FOR P GINGIVALIS FIMBRILLIN

S GORDONII AS A VECTOR FOR P GINGIVALIS FIMBRILLIN
S GORDONII 作为 P Gingivalis Fimbrillin 的载体
批准号:
2372351
负责人:
Ashu Sharma
金额:
$16.85万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-20 至 2000-09-19

项目摘要

项目成果

Ashu Sharma的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the investigator's Abstract): The broad, long-term goal of this project is to develop a system for continuous production of biologically active factors which block mucosal infections. The applicant proposes the development of genetically engineered strains of the commensal organism, Streptococcus gordonii, which expresses Porphyromonas gingivalis fimbrillin polypeptides capable of blocking adherence, and of inducing a protective immune response. The specific aims are: (1) to further characterize the expression system recently developed in our laboratory for P. gingivalis fimbrillin on the surface of S. gordonii; (2) to optimize a secretion system in S. gordonii for the production of P. gingivalis fimbrillin; and (3) to test these genetically engineered strains of S. gordonii in the rat model of periodontal disease for reduction of colonization with P. gingivalis and for protection against destructive periodontitis. S. gordonii was selected since it is a non-pathogenic commensal organism, universally found in the human oral cavity, and strains have been genetically engineered to express foreign antigens. P. gingivalis is an important pathogen in a well-established model of mucosal infection, periodontal disease, and its fimbrillin subunit was selected since it has been cloned and sequenced. Furthermore, P. gingivalis fimbrillin domains involved in adherence and in the immune response have been determined. Recombinant S. gordonii strains have been generated that express biologically active domains of fimbrillin and have shown that they are able to generate fimbrillin-specific immune response in rats following oral colonization as well as after parenteral immunization. Rats infected with P. gingivalis were selected as a model of mucosal infection in which to study the early steps in the disease process, namely adherence and colonization, since it is well characterized and provides a useful model to assess in vivo efficacy of a genetically engineered commensal organism producing factors which interfere with virulence. Therefore, studies are proposed to generate recombinant strains of S. gordonii able to either secrete or surface express important fimbrillin peptides, and capable of modulating P. gingivalis infection in a rat model of periodontal disease. Such genetically engineered strains of S. gordonii expressing fimbrillin peptides may be used as a vaccine against P. gingivalis infection, and as a model to study this novel approach to vaccines for other mucosal infections. The model can also be used for evaluating the utility of continuously expressed biologically active molecules by commensal organisms, directed to block colonization and other key early stages in the pathogenesis of mucosal infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
Novel Mechanisms of Peptidoglycan Synthesis in Tannerella forsythia
Novel Mechanisms of Peptidoglycan Synthesis in Tannerella forsythia
国内基金
海外基金
Streptococcus_salivarius 菌经肠肝轴定植肿瘤 微环境促进肝癌侵袭转移的分子机制研究
  • 批准号:
    Z24H160023
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    陈钢
  • 依托单位:
耳鼻咽喉头颈痛内菌Streptococcus mitis扰乱CAF细胞GSH代谢促进头颈鳞癌演进的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    只璟泰
  • 依托单位:
影响Streptococcus pyogenes CRISPR/Cas9脱靶的相关因素及其靶向特异性机制研究
  • 批准号:
    31770069
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    孙宇辉
  • 依托单位: